Cargando…
Androgen Receptor Splicing Variant-7 in Breast Cancer: Clinical and Pathologic Correlations
Androgen receptor (AR) inhibitor therapy is a developing treatment for AR-positive breast cancer (BC) with ongoing clinical trials. AR splicing variant-7 (AR-V7) is a truncated variant of AR that leads to AR inhibitor therapy resistance in prostate cancer; recent studies have identified AR-V7 in BC...
Autores principales: | Ferguson, Donna C., Mata, Douglas A., Tay, Timothy KY., Traina, Tiffany A., Gucalp, Ayca, Chandarlapaty, Sarat, D’Alfonso, Timothy M., Brogi, Edi, Mullaney, Kerry, Ladanyi, Marc, Arcila, Maria E., Benayed, Ryma, Ross, Dara S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863633/ https://www.ncbi.nlm.nih.gov/pubmed/34593966 http://dx.doi.org/10.1038/s41379-021-00924-5 |
Ejemplares similares
-
Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
por: Gucalp, Ayca, et al.
Publicado: (2011) -
Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
por: Cadoo, Karen A, et al.
Publicado: (2014) -
Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma
por: Zhu, Guo, et al.
Publicado: (2018) -
Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
por: Kyi, Chrisann, et al.
Publicado: (2021) -
Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate
por: Arcila, Maria E., et al.
Publicado: (2020)